These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17972174

  • 1. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature.
    Jhaveri K, Halperin P, Shin SJ, Vahdat L.
    Breast Cancer Res Treat; 2007 Dec; 106(3):315-8. PubMed ID: 17972174
    [Abstract] [Full Text] [Related]

  • 2. Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators.
    Dunn BK, Ryan A.
    Ann N Y Acad Sci; 2009 Feb; 1155():141-61. PubMed ID: 19250201
    [Abstract] [Full Text] [Related]

  • 3. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM.
    Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
    [Abstract] [Full Text] [Related]

  • 4. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
    Markopoulos C.
    Surg Oncol; 2008 Aug; 17(2):113-28. PubMed ID: 18178077
    [Abstract] [Full Text] [Related]

  • 5. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
    Lycette JL, Luoh SW, Beer TM, Deloughery TG.
    Breast Cancer Res Treat; 2006 Oct; 99(3):249-55. PubMed ID: 16752073
    [Abstract] [Full Text] [Related]

  • 6. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW.
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [Abstract] [Full Text] [Related]

  • 7. Effects of third-generation aromatase inhibitors on bone.
    McCloskey E.
    Eur J Cancer; 2006 May; 42(8):1044-51. PubMed ID: 16554149
    [Abstract] [Full Text] [Related]

  • 8. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC.
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [Abstract] [Full Text] [Related]

  • 9. Optimal sequence of hormonotherapy in advanced breast cancer.
    Bertelli G, Paridaens R.
    Curr Opin Oncol; 2006 Nov; 18(6):572-7. PubMed ID: 16988577
    [Abstract] [Full Text] [Related]

  • 10. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT.
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792
    [Abstract] [Full Text] [Related]

  • 11. Aromatase inhibitors and bone health.
    Bundred NJ.
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):60-7. PubMed ID: 19125005
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis.
    Gligorov J, Pritchard K, Goss P.
    Breast; 2007 Dec; 16 Suppl 3():S1-9. PubMed ID: 18061455
    [Abstract] [Full Text] [Related]

  • 13. Menopausal symptoms and adjuvant therapy-associated adverse events.
    Hadji P.
    Endocr Relat Cancer; 2008 Mar; 15(1):73-90. PubMed ID: 18310277
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant trials: Aromatase inhibitors in early breast cancer--are they alike?
    Monnier A.
    Cancer Treat Rev; 2006 Nov; 32(7):532-40. PubMed ID: 16978789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Are all aromatase inhibitors alike?
    Blackwell KL.
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():35-43. PubMed ID: 19101793
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Dixon JM, Renshaw L, Young O, Murray J, Macaskill EJ, McHugh M, Folkerd E, Cameron DA, A'Hern RP, Dowsett M.
    J Clin Oncol; 2008 Apr 01; 26(10):1671-6. PubMed ID: 18375896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.